Literature DB >> 15141339

Lymphocyte surge as a marker for immunorestitution disease due to Pneumocystis jiroveci pneumonia in HIV-negative immunosuppressed hosts.

V C C Cheng1, I F N Hung, A K L Wu, B S F Tang, C M Chu, K Y Yuen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15141339     DOI： 10.1007/s10096-004-1140-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  11 in total

1.  Immunorestitution diseases in patients not infected with HIV.

Authors:  V C Cheng; K Y Yuen; S S Wong; P C Woo; P L Ho; R Lee; R M Chan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-06       Impact factor: 3.267

Review 2.  Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients.

Authors:  V C C Cheng; P L Ho; R A Lee; K S Chan; K K Chan; P C Y Woo; S K P Lau; K Y Yuen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-11-07       Impact factor: 3.267

3.  Transient clinical deterioration in HIV patients with Pneumocystis carinii pneumonia after starting highly active antiretroviral therapy: another case of immune restoration inflammatory syndrome.

Authors:  Gillian L Dean; Deborah I Williams; Duncan R Churchill; Martin J Fisher
Journal:  Am J Respir Crit Care Med       Date:  2002-06-15       Impact factor: 21.405

Review 4.  Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risk.

Authors:  K A Sepkowitz; A E Brown; D Armstrong
Journal:  Arch Intern Med       Date:  1995-06-12

5.  Pneumocystis carinii pneumonia in patients with primary brain tumors.

Authors:  J W Henson; J K Jalaj; R W Walker; D E Stover; A O Fels
Journal:  Arch Neurol       Date:  1991-04

6.  Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia.

Authors:  M Wislez; E Bergot; M Antoine; A Parrot; M F Carette; C Mayaud; J Cadranel
Journal:  Am J Respir Crit Care Med       Date:  2001-09-01       Impact factor: 21.405

Review 7.  Immunorestitution disease involving the innate and adaptive response.

Authors:  V C Cheng; K Y Yuen; W M Chan; S S Wong; E S Ma; R M Chan
Journal:  Clin Infect Dis       Date:  2000-06-20       Impact factor: 9.079

8.  Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases.

Authors:  S M Arend; F P Kroon; J W van't Wout
Journal:  Arch Intern Med       Date:  1995 Dec 11-25

9.  Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors.

Authors:  A Slivka; P Y Wen; W M Shea; J S Loeffler
Journal:  Am J Med       Date:  1993-02       Impact factor: 4.965

10.  Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital.

Authors:  K A Sepkowitz; A E Brown; E E Telzak; S Gottlieb; D Armstrong
Journal:  JAMA       Date:  1992-02-12       Impact factor: 56.272
View more
  7 in total

1.  Neither classical nor alternative macrophage activation is required for Pneumocystis clearance during immune reconstitution inflammatory syndrome.

Authors:  Zhuo-Qian Zhang; Jing Wang; Zachary Hoy; Achsah Keegan; Samir Bhagwat; Francis Gigliotti; Terry W Wright
Journal:  Infect Immun       Date:  2015-09-14       Impact factor: 3.441

2.  Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients.

Authors:  H A Torres; R F Chemaly; R Storey; E A Aguilera; G M Nogueras; A Safdar; K V I Rolston; I I Raad; D P Kontoyiannis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-06       Impact factor: 3.267

3.  Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation.

Authors:  Elena N Atochina-Vasserman; Andrew J Gow; Helen Abramova; Chang-Jiang Guo; Yaniv Tomer; Angela M Preston; James M Beck; Michael F Beers
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

4.  Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.

Authors:  Jing Wang; Francis Gigliotti; Samir P Bhagwat; Thaddeus C George; Terry W Wright
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

Review 5.  The unmasking of Pneumocystis jiroveci pneumonia during reversal of immunosuppression: case reports and literature review.

Authors:  Alan K L Wu; Vincent C C Cheng; Bone S F Tang; Ivan F N Hung; Rodney A Lee; David S Hui; Kwok Y Yuen
Journal:  BMC Infect Dis       Date:  2004-12-09       Impact factor: 3.090

6.  Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole.

Authors:  Jun Won Park; Jeffrey R Curtis; Min Jung Kim; Hajeong Lee; Yeong Wook Song; Eun Bong Lee
Journal:  Arthritis Res Ther       Date:  2019-09-14       Impact factor: 5.156

7.  Immune Reconstitution Inflammatory Syndrome Associated with Pneumocystis jirovecii Pneumonia and Cytomegalovirus Colitis in a Patient with Rheumatoid Arthritis.

Authors:  Natsuki Shima; Ayako Kokuzawa; Keisuke Saito; Yasuyuki Kamata; Takao Nagashima; Kojiro Sato
Journal:  Intern Med       Date:  2021-07-10       Impact factor: 1.271
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.